baber/WOPTO huggingface dataset:
Patent NZ-328098-A (NZ)
Title: Two piece formers to form void spaces in concrete components
Inventor: MCGLASHAN DONALD LAING
IPC: E04G15/06
Filed: 1998-06-16
Abstract: void former for concrete construction has first and second like portions 3 that are placed together to form the former of a required size and dimension.  The former portions of molded foam plastic include a honeycomb, lattice, or mesh-like interior 6.
Patent NZ-330119-A (NZ)
Title: Pyrazolopyrimidines as crf receptor antagonists
Inventor: CHEN CHEN
IPC: A61K31/5375
Filed: 1997-01-30
Abstract: Disclosed are compounds of formula (I), including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R1 is NR4R5 or OR5; R2 is C1-6alkyl, C1-6alkyloxy or C1-6alkylthio; R3 is hydrogen, C1-6alkyl, C1-6alkylsulfonyl, C1-6alkylsulfoxy or C1-6alkylthio; R4 is hydrogen, C1-6alkyl, mono- or di(C3-6cycloalkyl)methyl, C3-6cycloalkyl, C3-6alkenyl, hydroxyC1-6alkyl, C1-6alkylcarbonyloxyC1-6alkyl or C1-6alkyloxyC1-6alkyl; R5 is C1-8alkyl, mono- or di(C3-6cycloalkyl)methyl, Ar1CH2, C1-6alkyloxyC1-6alkyl, hydroxyC1-6alkyl, C3-6alkenyl, thienylmethyl, furanylmethyl, C1-6alkylthioC1-6alkyl, morpholinyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, di(C1-6alkyl)amino, C1-6alkylcarbonylC1-6alkyl, C1-6alkyl substituted with imidazolyl; or a radical of the formula -Alk-O-CO-Ar1; or R4 and R5 taken together with the nitrogen atom to which they are attached may form an optionally substituted pyrrolidinyl, piperidinyl, homopiperidinyl or morpholinyl group; having CRF receptor antagonistic properties; pharmaceutical compositions containing such compounds as active ingredients; methods of treating disorders related to hypersecretion of CRF such as depression, anxiety, substance abuse, by administering an effective amount of a compound of formula (I).
Patent NZ-331189-A (NZ)
Title: Method of detection of influenza virus using neuraminidase binders
Inventor: REECE PHILIP A
IPC: G01N33/569
Filed: 1997-02-26
Abstract: The invention provides a method of detection of influenza virus which utilizes compounds able to bind specifically to the active site of influenza virus neuraminidase, and novel compounds for use in the method.
Patent NZ-333527-A (NZ)
Title: Suppression of polarization hole burning with an acousto-optic modulator
Inventor: FRASCOLLA MASSIMO
IPC: H04B10/17
Filed: 1998-12-22
Abstract: The specification describes an apparatus and method for reducing polarization hole burning in a rare-earth-doped fiber amplifier within an optical communication system.  The method involves converting an optical carrier having a characteristic wavelength into a polarization-rotating optical carrier. The apparatus includes (i) a polarization-fixing device optically coupled in the optical transmission system to transform the optical carrier to a polarized optical carrier, and (ii) an acousto-optic modulator positioned to receive a first portion of the polarized optical carrier and to orthogonally convert the polarization of the polarized optical carrier and to shift the polarized optical carrier by a modulation frequency. The apparatus and method further includes a polarization beam combiner optically coupled to receive the orthogonally polarization converted and frequency shifted polarized signal and a portion of the original polarized optical carrier. The polarization beam combiner produces a polarization-rotating carrier signal that is transmitted downstream in the optical communication system to a rare-earth-doped fiber amplifier.
Patent NZ-502199-A (NZ)
Title: Direct hair dye compositions and methods containing three different anthraquinones
Inventor: ANDERSON JAMES S
IPC: C09B67/22
Filed: 1998-06-03
Abstract: Described is an anthraquinone mixture comprising three different anthraquinone compounds.  The compounds have the formula wherein: R1 and R2 are, independently, monohydroxy C2 -C6 alkyl, straight chain or branched chain, with the proviso that in two of the anthraquinones, R1 and R2 are the same.  As a consequence those anthraquinones are symmetric. In the third of the anthraquinones, R1 and R2 differ.  As a consequence that anthraquinone is asymmetric. The two symmetric anthraquinone compounds in combination are present in the mixture in an amount of about 30% to about 90% by weight, based on the total weight of the mixture. The asymmetric anthraquinone is present in the mixture in an amount of about 10% to about 70% by weight, based on the total weight of the mixture.
Patent NZ-511798-A (NZ)
Title: Minimal promoters comprising a promoter not linked to its native enhancer and such minimal promoters linked to an antigen
Inventor: FULLER JAMES T
IPC: A61K35/76
Filed: 1999-10-19
Abstract: Minimal promoter sequences are described. Reagents including a nucleic acid molecule which contains these minimal promoter sequences are also described. Methods for constructing these reagents, and methods for using these reagents are also described. Particularly described are minimal promoters, consisting of a promoter sequence not coupled to its native enhancer sequence, operably linked to a coding sequence for an antigen which are useful as a vaccine for immunizing a mammalian subject.
Patent NZ-514073-A (NZ)
Title: Taxane formulations having improved solubility
Inventor: HOLTON ROBERT A
IPC: C07D405/12
Filed: 2001-02-02
Abstract: A method for preparing a pharmaceutical composition comprising mixing a taxane and at least one nonaqueous, pharmaceutically acceptable solvent, wherein the taxane has a solubility in ethanol at room temperature of at least 200mg/ml and an ID50 value determined relative to the HCT116 cell line that is at least 4 times less than that of paclitaxel, the taxane can have the formula (1).
Patent NZ-520839-A (NZ)
Title: Device for fixing implants on or in a bone
Inventor: GOLDHAHN JORG
IPC: A61B17/86
Filed: 2000-04-20
Abstract: The present invention concerns a fastening element for use in bone, and in particular to a device for fixating implants on or in bone. The device may have a longitudinal axis for anchoring in bone and may comprise a core and at least one wing extending from the core. The wing may have an enlarged peripheral portion adapted to contact bone. A cross-section of the device transverse to the longitudinal axis may have first and second portions, the first portion comprising the core and defining a first cross-sectional area, the second portion comprising the enlarged peripheral portion of the at least one wing and defining a second cross-sectional area, and the second cross-sectional area preferably is greater than the first cross-sectional area. The ratio of the second portion to the first portion preferably being at least about 3:
Patent NZ-521310-A (NZ)
Title: Pressure sensitive mat with breathing tube apparatus
Inventor: FITZGERALD SANFORD G
IPC: H01H3/14
Filed: 2001-02-23
Abstract: Patient monitoring systems and, more particularly, devices and systems used to monitor bed patients in hospital or other care-giving environments. A pressure sensitive mat is completely sealed around its exterior edges, the interior of the mat being kept in communication with the atmosphere by way of a section of flexible tubing which encloses the attached electrical line. One end of the tubing is sealed inside of the mat and the other end is open to the atmosphere, thereby providing a passageway for air to reach the interior of the mat. This arrangement protects the interior of the mat from exposure to fluids near the perimeter of the mat and allows the mat-portion to be completely submersed without adverse effect, if that should become necessary.
Patent NZ-523114-A (NZ)
Title: Method of treating several aspects of cardiovascular disease and cerebral vascular or peripheral vascular disease in mammals with rapamycin
Inventor: AZROLAN NEAL IVAN
IPC: C07D498/14
Filed: 2001-06-14
Abstract: Described is the use of a rapamycin compound such as an ester, ether, oxime, hydrazone or hydroxylamine of rapamycin in a method of treating or inhibiting cardiovascular, cerebral vascular, or peripheral vascular disease in a mammal in need thereof.
Patent NZ-525705-A (NZ)
Title: Cyanopyrrolidine derivatives
Inventor: FUKUSHIMA HIROSHI
IPC: A61P35/04
Filed: 2001-11-09
Abstract: Cyanopyrrolidine compounds of formula (1) are described, for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases improved by inhibition of dipeptidyl peptidase IV.
Patent NZ-526387-A (NZ)
Title: Imidazole derivatives having a steroid C17,20-lyase- inhibitory activity, their production process and use thereof
Inventor: TASAKA AKIHIRO
IPC: C07D233/54
Filed: 2001-11-16
Abstract: A compound of the formula (I), its salt or a prodrug having a steroid C17,20-lyase-inhibitory activity and useful for the therapy and prophylaxis of tumor such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof is disclosed, wherein n is an integer of 1 to 3; and Ar is an optionally substituted aromatic ring Also disclosed is a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like.
Patent NZ-527603-A (NZ)
Title: Fastener collation strip
Inventor: TUCKER KEVIN M
IPC: B25C3/00
Filed: 2003-08-14
Abstract: A fastener assembly comprising a plurality of fasteners arranged in a row, each fastener including a head and an elongated shank and a carrier including a plurality of connected carrier sleeves for receiving and surrounding a portion of an associated fastener. Each of the carrier sleeves includes an axis, an upper breakable portion, a middle wall portion, a lower breakable portion, a pedestal associated with the lower breakable portion, the pedestal extending axially away from the lower breakable portion, and a pair of notches in the lower breakable portion opening toward the head of the associated fastener.
Patent NZ-532040-A (NZ)
Title: Precise optical scanning location of microtiter plate and sample holding positions
Inventor: LANGEVELD PIETER CORNELIS
IPC: G06T7/00
Filed: 2002-10-10
Abstract: In order to locate the position of a microtiter plate 35 that holds a plurality of sample holding containers 33 at predetermined fixed positions on the plate, and more particularly the precise locations of the containers, the holder is illuminated by a light source 43 and a sensor 37 receives an image of the holder and generates image pixel data including the location and intensities of the pixels. The image data is stored into a memory 43 by a processor 39 which also compares the intensities of the pixels with a threshold, determines the holder position on the basis of this comparison, uses a digital match mask that corresponds with the holder to find the best match between the digital match mask and the holder on the holder position, and determines container positions for holding the test samples within the holder position form the best match.
Patent NZ-532541-A (NZ)
Title: Synthesis of 2-aralkoxy adenosines and 2-alkoxy adenosines
Inventor: MOORMAN ALLAN R
IPC: C07H19/16
Filed: 2002-10-24
Abstract: A method for synthesis of a 2-aralkyloxyadenosine or a 2-alkoxyadenosine, comprising: a) activating a guanosine compound b) hydrolysis of a compound resulting from step (a) c) treating a compound resulting from step (b) with an alkylating agent d) treating a compound resulting from step (c) with an amine to provide a 2-aralkyloxyadenosine or a 2-alkoxyadenosine compound, is described. In particular, a process for the preparation of a compound of formula I is also described.
Patent NZ-532991-A (NZ)
Title: Compositions and methods for treating set gypsum
Inventor: YU QIANG
IPC: C04B41/50
Filed: 2002-11-19
Abstract: A composition and method for treating a set gypsum-containing material are disclosed. The composition is formed from at least water at least one trimetaphosphate salt, at least one monobasic phosphate salt, and at least one acyclic polyphosphate salt having at least three phosphate units. The method comprises applying to a set gypsum material at least two of the following inorganic phosphates: at least one monobasic phosphate salt, at least one trimetaphosphate salt, and at least one acyclic polyphosphate salt having at least three phosphate units. The method is suitable for inhibiting re-calcination of a set gypsum containing material, and/or for enhancing the strength, surface hardness, paintability, abrasion resistance, and/or water erosion resistance of a set gypsum-containing material. Also disclosed is a method of making a set gypsum-containing material.
Patent NZ-533543-A (NZ)
Title: A communication method and an interface device
Inventor: DEDERA RONALD JOSEPH
IPC: H04Q3/62
Filed: 2002-11-15
Abstract: A method of communicating between a first device operating under a first protocol and a second device operating under a second protocol comprises: a. receiving data from the first device according to the first protocol; b. extracting the data according to an intermediate data format; c. reformatting the data according to the second protocol and d. transmitting the data to the second device according to the second protocol wherein one or more software engines are used for each of the input stage (step a. and b.) and the output stage (steps c. and d.); wherein the software engines are of a common structure and operation of each software engine is defined by configuration data related to the processing level of the software engine. A system for providing an abstract interface to communicate with a device includes: i. a chain of two or more software engines wherein each software engine is upper interfaced to the software engines preceding it and lower interfaced to the software engine following it; ii. a first software engine in the chain providing an upper interface and iii. a last software engine in the chain adapted to manage and execute a lower direct interface with a device; wherein the upper interface of the first software engine provides an generalized interface of the highest level of abstraction and each successive member of the chain provides a decreasing level of abstraction; wherein each member transforms data received through its upper and lower interfaces according to that member's level of abstraction and wherein the software engines are of a common structure and operation of each software engine is defined by configuration data related to its corresponding level of abstraction.
Patent NZ-536053-A (NZ)
Title: Cripto-specific antibodies, or biologically functional fragments thereof for use in the manufacture of a medicament for the inhibition of angiogenesis in a subject having a tumor
Inventor: SANICOLA-NADEL MICHELE
Filed: 2002-10-01
Abstract: Disclosed are Cripto-specific antibodies, or biologically functional fragments thereof for use in the manufacture of a medicament for the inhibition of angiogenesis in a subject having a tumor. It specifically binds to an epitope consisting of amino acid residues 46-62 if SEQ ID NO 1 or 2.
Patent NZ-545289-A (NZ)
Title: Vaccine formulations comprising an oil-in-water emulsion
Inventor: PARISOT ALEXIS GUY ANDRE
IPC: A61K39/295
Filed: 2004-07-26
Abstract: Disclosed is a vaccine composition comprising an injectable oil-in-water (O/W) emulsion, comprising: (i)an aqueous solution containing at least one immunogen; (ii) a mineral oil; (iii) a non-ionic lipophilic surfactant; (iv) a non-ionic hydrophilic surfactant having a high hydrophilic-lipophilic balance (HLB) value between 13 and 40; and (v) a non-ionic hydrophilic surfactant having a low hydrophilic-lipophilic balance (HLB) value between 9 and 13.
Patent NZ-547079-A (NZ)
Title: Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
Inventor: ELIAZ ROM E
IPC: A61K38/095
Filed: 2004-11-16
Abstract: Provided is a pharmaceutical composition comprising:a suspending vehicle comprising a non-aqueous liquid solvent selected from the group consisting of benzyl benzoate, lauryllactate, and lauryl alcohol, and a particle preparation comprising a protein, sucrose, methionine, and a citrate buffer in a weight ratio of about 1:2:1:2.15, wherein the particle preparation is dispersed in the suspending vehicle. Further provided are similar compositions further comprising a specified lipid and osmotic delivery devices comprising the compositions
Patent NZ-547207-A (NZ)
Title: Twin overhead rail engine assembly station
Inventor: MCCAFFREY MICHAEL G
Filed: 2006-05-12
Abstract: A quadrail ergonomic assembly apparatus includes at least two pathways 11 and 13 that are mounted to a static structure above a surface and one or more carriages 20, 22, 24, 26, 28 that move in at least two directions disposed within the pathways. Each carriage is suspended above the surface from the pathways and maintains at least one engine part 34, 54, 84, 104, 134 in place above the surface and permits movement of the engine part that it holds in at least four directions. The assembly apparatus serves to permit the manoeuvring and alignment of the heavy engine parts for assembly without excessive exertion by the assemblers.
Patent NZ-547937-A (NZ)
Title: Voice prosthesis device with movable valve member harder than seat against which it closes
Inventor: NELSON JESSE N
Filed: 2006-06-15
Abstract: A voice prosthesis device (20) provides a passageway (36) between a tracheal end (24) of the device and an esophageal end (26) of the device (20). A valve in the passageway (36) includes a seat (54) having a first hardness and a movable valve member (52) having a second hardness harder than the first hardness. The movable valve member (52) closes against the seat (54) to close the valve.
Patent NZ-552600-A (NZ)
Title: A gas burner with two gas flow passages
Inventor: GRAHAM LINDSAY GEORGE
IPC: F23D14/02
Filed: 2005-07-13
Abstract: A gas burner comprises a first gases flow passage 52 with an inlet and an outlet, a source of oxidising gases at the inlet of the first passage 52, a second gases flow passage with an inlet and an outlet, a source of oxidising gases at the inlet of the second passage, the outlet of the first passage 52 proximate to the outlet second passage, a fuel gas jet 46 configured to supply fuel to the second passage, a flame locating means 49 within the second passage 52 sheltered from the oxidising gases in the first passage 52, and a burner cap 3 spaced downstream from the outlet of the second flow passage. The burner cap 3 extends transversely to the outlet of the second flow passage. Oxidising gas is typically supplied by fan 41 and flows over baffle 54 to the first passage 52 via circumferentially spaced slots in the burner housing.
Patent NZ-555195-A (NZ)
Title: Multiple pay combination gaming apparatus
Inventor: BENNETT NICHOLAS
Filed: 2007-05-15
Abstract: A gaming machine comprises credit input means to receive credit for wagering on game plays of a game playable on the gaming machine; display means comprising one or more displays; one or more input devices that allow the player to specify a wager to stake on a variable number of the outcomes before the outcomes are displayed on the display means and a game controller that receives inputs from the one or more input devices, determines from the inputs the number of outcomes on which a wager has been staked, reduces a balance of credit that has been received by the credit input means, and randomly selects outcomes for the game. The game controller further controls the display means to display representations of the game and display an indicator of the determined number of outcomes on which a wager has been staked as a gauge and display an outcome indicator that indicates any outcomes that are associated with the wager that has been staked and the number of outcomes represented by the gauge that result in a winning combination. The gaming machine also has a prize payment means controlled by the game controller to pay a prize for any said winning combination that occurs in at least one of the outcomes on which the player has staked a wager and which are represented by the gauge.
Patent NZ-556310-A (NZ)
Title: Increased conductivity and enhanced electrolytic and electrochemical processes
Inventor: PASHLEY RICHARD MARK
IPC: C25C3/02
Filed: 2005-12-23
Abstract: A method of conducting a current through an aqueous liquid is provided. The method comprises first degassing the aqueous liquid to produce a degassed aqueous liquid, wherein at least 80% of dissolved gas is removed from the aqueous liquid, and applying an electric field to the degassed aqueous liquid so as to cause an electric current to pass therethrough.
Patent NZ-561926-A (NZ)
Title: Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance
Inventor: HUGHES PAUL SHANE
IPC: A23L5/41
Filed: 2006-03-28
Abstract: The disclosure relates to a composition containing: (A) at least 10 micrograms of particular substituted pyrroles (represented by the formula shown herein) per kg of dry matter; and (B) at least 100 mg per kg of dry matter of a pyranone selected from the group consisting of maltol, 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one and combinations thereof; which composition, when dissolved in water at a dry solids content of 0.1 wt.%, exhibits: (i) an absorption at 280 nm (A280) that exceeds 0.01, preferably exceeds 0.05; and ii. an absorption ratio A280/560 of at least 100, preferably of at least 200. The present composition can advantageously be used as an additive in beverages or foodstuffs to prevent or reduce light induced flavour changes. The disclosure also relates to a process for the manufacture of the aforementioned composition.
Patent NZ-563488-A (NZ)
Title: Dihydrothienopyrimidines for the treatment of inflammatory diseases
Inventor: POUZET PASCALE
IPC: A61K31/519
Filed: 2006-04-19
Abstract: Disclosed is a compound of formula 1 wherein X denotes O, S, SO or SO2; and wherein the rest of the substituents are disclosed within the specification, or a pharmacologically acceptable salt, diastereomer, enantiomer, racemate, hydrate or solvate thereof. Also disclosed are intermediates and the use of the compound of formula 1 in the manufacture of a medicament for treating diseases which can be treated by inhibition of the PDE4 enzyme such as inflammatory or obstructive diseases.
Patent NZ-568878-A (NZ)
Title: Vehicle apparatus for moving a wheelchair with wheels placed in vertical plane in vehicle and chair movable to alongside a door of vehicle
Inventor: GAGHIS IGOR
IPC: A61G3/02
Filed: 2008-06-05
Abstract: The apparatus consists of a first inner portion pivotally connected to an anchorage that can be fixed to a vehicle floor and that is movable in a horizontal plane, and a second outer portion connected to the first portion that is movable in a vertical plane. A wheelchair can thus be moved to be stored in a vehicle with its wheel axis transverse to the longitudinal direction of the vehicle. Additionally the wheelchair can be positioned alongside a door using only the first and second portions, and the wheels are placed in a vertical plane so as to make the wheelchair more accessible in the event of a power failure.